All reported cases of TBL1XR1-RARB-positive APL have been managed with ATRA/ATO combined with chemotherapy, with three patients ultimately undergoing hematopoietic stem cell transplantation. The gene discussed is RARB; the disease is acute promyelocytic leukemia.